Clinical trials
TB clinical trials
Below are recruiting tb clinical trials, each written for real people, not researchers. We’re tracking 67 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06984887Enrolling by invitation
New TB tests study in Pakistan for screened patients
This study tests new, easier ways to diagnose TB, like tongue swabs or sputum tests. It is for people who have already had a chest X-ray with a computer-aided detection (CAD) score.
Islamabad, Federal CapitalAges 12 years+ - NCT06971952Recruiting
Tuberculosis study in rural malnourished communities
This study looks at how TB affects people in rural areas who may also be malnourished. It aims to understand and improve TB care for these communities.
Haydom, Manyara RegionAges Any age - NCT06905522RecruitingPhase 3
Tuberculosis treatment trial for new patients
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
BeijingAges 18–65 - NCT05824871RecruitingPhase 3
Oral drug for rifampicin-resistant lung tuberculosis
This Phase 3 trial tests an oral medicine (Sudapyridine/WX-081) to treat people with rifampicin-resistant pulmonary tuberculosis. It compares how well the study drug works when you stop prior tuberculosis medicines and go through a short “washout” period first.
Beijing, Beijing MunicipalityAges 18–65 - NCT06751706Enrolling by invitation
Testing blood for TB in patients and their household contacts
This study looks for TB bacteria in the blood of people with active tuberculosis and their close contacts at home. It aims to find better ways to detect TB early and prevent its spread.
KampalaAges 18 years+ - NCT06744179Enrolling by invitation
Post-TB Sequelae Study: How the body heals after TB
This study looks at how the body recovers from tuberculosis (TB). It compares people who have had TB to those who have not, to understand long-term health effects. Participants will be asked to come for follow-up visits in Dhaka.
Dhaka, Dhaka DivisionAges 6 months+ - NCT06593080Recruiting
Testing a TB diagnosis checklist for children
This study is testing a new way to diagnose TB in children using simple symptom checklists. It aims to see if these checklists can help doctors find TB earlier and more accurately, especially in children who are very young or have other health problems.
Chingola, CopperbeltAges Up to 14 years - NCT06568484RecruitingPhase 2/Phase 3
Preventing TB with bedaquiline in people exposed to TB
This study tests if bedaquiline can prevent tuberculosis (TB) in people who have been in close contact with someone with active TB, including people living with HIV. If you qualify, you would take the study medicine and be monitored to see if it prevents you from developing TB.
UlaanbaatarAges Any age - NCT06498414RecruitingPhase 2/Phase 3
Shorter and safer treatment for latent TB
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
CotonouAges 5 years+ - NCT06352970Recruiting
TB infection and placenta function study
This study looks at how tuberculosis (TB) infection might affect the placenta and its function during pregnancy. If you are pregnant and giving birth soon, researchers want to learn if TB changes how the placenta grows and works.
Addis AbabaAges 18 years+ - NCT06281834RecruitingPhase 1
Dolutegravir levels with TB prevention in children
This study tests how dolutegravir (an HIV medicine) works in children when taken with weekly rifapentine and isoniazid (medicines to prevent tuberculosis). It may help find the right dose for kids who have HIV and are at risk for TB.
Ibadan, Oyo StateAges 4 weeks–11 years - NCT06253715RecruitingPhase 3
Shorter TB treatment for children
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
ChennaiAges birth–9 years - NCT06114628RecruitingPhase 2
Finding the best treatment for lung TB (PARADIGM4TB)
This study tests different ways to treat active lung TB that is not resistant to rifampicin. It aims to find the best treatment duration and combination to cure TB and prevent it from coming back.
ChisinauAges 18 years+ - NCT06153069RecruitingPhase 4
Shorter tuberculosis treatment for people without symptoms
This trial tests a shorter treatment regimen for people with tuberculosis (TB) who don't have symptoms. If you have TB bacteria in your lungs but no cough, fever, night sweats, or weight loss, this study may offer a more convenient treatment option.
Beijing, Beijing MunicipalityAges 14–80 - NCT06022146RecruitingPhase 3
Short TB prevention for school contacts
This trial tests a very short (one-month) medicine course to prevent tuberculosis (TB) in students and school staff who have been exposed to someone with active TB. If you have latent TB infection (the germs are in your body but you're not sick), this treatment aims to stop it from turning into active TB disease.
Anshun, GuiyangAges 13 years+ - NCT05317247Recruiting
Cough sound test to quickly triage possible tuberculosis
This trial checks whether listening to your cough on an audio recording can help triage—meaning sort—people who may have tuberculosis (TB). If you have had a cough for at least two weeks, the study may help doctors decide who needs further TB testing.
Cape Town, Western CapeAges 12 years+ - NCT05059626Enrolling by invitationPhase 4
Test simvastatin and Duavee for endometriosis symptoms
This trial studies whether simvastatin and Duavee can improve endometriosis-related symptoms linked to small blood-vessel problems. You may be eligible if you’re a woman aged 18–45 with confirmed endometriosis and meet safety requirements.
New Haven, ConnecticutAges 18–45 - NCT04923958Recruiting
Testing new TB screening and diagnostic tests
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
TbilisiAges 12 years+ - NCT04700579Recruiting
Study lung changes before and after treatment for active TB
This study looks at changes in the lungs and immune system before TB treatment and again after treatment. By sampling lung fluid and comparing it over time, researchers hope to learn signatures that reflect how TB responds to care.
Cape Town, Western CapeAges 18–60
Hear when a new TB trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tb?
- Yes. Clin2 currently lists 67 recruiting tb studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tb trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tb trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.